Provided by Tiger Trade Technology Pte. Ltd.

Humacyte, Inc.

0.6422
-0.0392-5.75%
Pre-market: 0.65000.0078+1.21%04:01 EDT
Volume:9.37M
Turnover:6.14M
Market Cap:178.53M
PE:-1.29
High:0.7000
Open:0.6741
Low:0.6345
Close:0.6814
52wk High:2.55
52wk Low:0.5261
Shares:278.00M
Float Shares:245.00M
Volume Ratio:0.56
T/O Rate:3.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4975
EPS(LYR):-0.2582
ROE:-547.87%
ROA:-49.87%
PB:5.71
PE(LYR):-2.49

Loading ...

Humacyte Cut to Speculative Buy From Buy by Benchmark

Dow Jones
·
Mar 31

Humacyte downgraded to Speculative Buy from Buy at Benchmark

TIPRANKS
·
Mar 31

Humacyte Inc : Benchmark Cuts to Speculative Buy From Buy; Cuts Target Price to $1 From $10

THOMSON REUTERS
·
Mar 31

Benchmark Downgrades Humacyte to Speculative Buy From Buy, Adjusts Price Target to $1 From $11

MT Newswires Live
·
Mar 31

Humacyte Is Maintained at Neutral by Piper Sandler

Dow Jones
·
Mar 31

Humacyte price target lowered to $1 from $3 at Piper Sandler

TIPRANKS
·
Mar 30

Humacyte Is Maintained at Buy by BTIG

Dow Jones
·
Mar 27

Humacyte Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 27

Humacyte posts bigger-than-expected Q4 loss

Reuters
·
Mar 27

Humacyte FY2025 net loss narrows to $40.8 million; revenue rises to $2.0 million

Reuters
·
Mar 27

Humacyte Q4 EPS $(0.13), Inline, Sales $467.000K Miss $1.343M Estimate

Benzinga Earnings
·
Mar 27

BRIEF-Humacyte Q4 Basic EPS USD -0.13

Reuters
·
Mar 27

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 27

BRIEF-Humacyte Appoints Rick Mcelheny As Senior Vice President Of Business Development

Reuters
·
Mar 26

Humacyte Appoints Rick Mcelheny as Senior Vice President of Business Development

THOMSON REUTERS
·
Mar 26

Press Release: Humacyte Appoints Rick McElheny as Senior Vice President of Business Development

Dow Jones
·
Mar 26

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 25

Humacyte Inc expected to post a loss of 13 cents a share - Earnings Preview

Reuters
·
Mar 24

Humacyte to host fourth-quarter and full-year 2025 financial results webcast and conference call

Reuters
·
Mar 23

Humacyte to Announce 2025 Fourth Quarter and Year End Financial Results and Provide Business Update on March 27, 2026

THOMSON REUTERS
·
Mar 23